Fig. 3From: Therapeutic effects of Lucilia sericata larval excretion/secretion products on Leishmania major under in vitro and in vivo conditionsa–d Dose–response curves of tested ES of Lucilia sericata larvae and Glucantime against Leishmania major promastigotes (half maximal inhibitory concentration; IC50) at 24 h, 48 h and 72 h. Area under the curve indicates the relationship between the number of parasites and the tested doses compared with the negative control. a Crude ES, b > 10-kDa ES, c < 10-kDa ES, d GlucantimeBack to article page